Clinical Trials
5 trialsNCT07519564 2026-04-09
A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia
Kexing Biopharm Co., Ltd.
Phase 1 Not yet recruiting
NCT05865535 2026-01-08
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
AVEO Pharmaceuticals, Inc.
Phase 1 Recruiting
NCT06898255 2025-06-05
A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
Genfleet Therapeutics (Shanghai) Inc.
Phase 1 Recruiting
NCT04803305 2024-01-12
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Pfizer
Phase 1 Completed
NCT04299048 2023-12-14
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Pfizer
Phase 1 Completed